–
Статьи в журналах
-
- 2024 Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
- Burris Howard A., Okusaka Takuji, Vogel Arndt, Lee Myung Ah, Takahashi Hidenori, Breder Valeriy, Blanc Jean-Frédéric, Li Junhe, Bachini Melinda, Żotkiewicz Magdalena, Abraham Jayne, Patel Nikunj, Wang Julie, Ali Muzammil, Rokutanda Nana, Cohen Gordon, Oh Do-Youn
- в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 25, № 5, с. 626-635 DOI